BioSante Pharmaceuticals Inc. (BPAX) Profile

Profile for BioSante Pharmaceuticals Inc. (BPAX)

After Hours: $ 0.87

0.019 (+2.23%)

Volume: 41.03 k

7:02 PM EST Feb 10, 2012


Business Description: Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism.

Address:	111 Barclay Boulevard, Suite 280, Lincolnshire, IL, 60069
Telephone:	(847) 478-0500	Website:	www.biosantepharma.com
Facsimile:	(847) 478-9152	Email:	tswanson@troutgroup.com


Details

CEO:	Mr. Stephen M. Simes
Employees:	45	Market Cap:	93.62 m
Issue Type:	CS
Auditor:	Deloitte & Touche LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0001023024
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Biological Product (except Diagnostic) Manufacturing (325414)
SIC:	Biological Products, Except Diagnostic Substances (2836)

Tags for BioSante Pharmaceuticals Inc.

Research stocks or mutual funds related to BioSante Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to BPAX. The keywords below have been associated to BPAX by either user submission or electronic means.

herbal menopause dhea hormone symptoms of menopause testosterone menopause increase libido female menopause know menopause women's libido pharmaceuticals companies thyroid hormone replacement decreased libido women women libido dupont pharmaceuticals decreased libido Biological Products estrogen replacement therapy womens libido woman libido human growth hormone pharma license libido sexuality female progesterone cream drug delivery women menopause pharmaceutical sales hormones aphrodisiacs for women testosterone patch menopause hormone replacement therapy no libido pharma Testosterone replacement therapy pharmaceutical development loss of libido pharmaceutical reports pharmaceutical magazine hormones female Drugs women testosterone natural hrt testosterone women low female enhancement bioidentical hormone replacement therapy menopause treatment female libido drug testosterone female low elan pharmaceutical pharmaceutical sale menopause relief

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.